ArticleIEEE transactions on artificial intelligence2026
Omics-based Cancer Prognosis Across Ethnic Groups: From Feature Engineering to Disparity Detection and Mitigation.
Article in IEEE transactions on artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Bridging ancestry gaps in genomic risk prediction with tabular foundation models.Bioinformatics (Oxford, England) · 2026Article
- Bridging Ancestry Gaps in Genomic Risk Prediction with Tabular Foundation Models.bioRxiv : the preprint server for biology · 2026Article
- Equitable Health Intelligence: An Open Benchmark of Multi-Population Machine Learning for Omics-Based Cancer Prognosis.bioRxiv : the preprint server for biology · 2026Article
- Data Representation Bias and Conditional Distribution Shift Drive Predictive Performance Disparities in Multi-Population Machine Learning.bioRxiv : the preprint server for biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Artificial Intelligence (AI) models replicate human decision-making processes across numerous applications, including precision medicine using biomedical datasets. However, existing approaches suffer from two major challenges: unequal representation of ethnic groups resulting in data inequality, and the high dimensional nature of data, limiting generalization and interpretation. Such datasets hamper the performance of AI models for underrepresented or data disadvantaged groups, where the large number of features further complicates analysis. This paper introduces a machine learning approach for omics-based cancer prognosis across ethnic groups, employing an autoencoder based feature engineering method for feature extraction to detect disparities arising from biomedical data inequality and mitigate these disparities using transfer learning. The presented approach utilizes the feature engineering method to select and extract informative features, followed by machine learning schemes across ethnic groups, incorporating mixture learning, independent learning, and transfer learning that consider diverse group compositions to identify performance gaps and improve outcomes for underrepresented or data disadvantaged groups. Experimental analysis demonstrates that 22.34% of machine learning tasks exhibit performance disparities, which are mitigated using transfer learning for African American data disadvantaged group of mRNA Expression features from The Cancer Genome Atlas dataset. Similarly, across DNA methylation and MicroRNA Expression omics datasets, the presented approach effectively identified and reduced disparities in data disadvantaged groups compared to conventional feature engineering methods. Furthermore, Statistical tests validate the efficacy of the presented approach in detecting these disparities and enhancing the performance using transfer learning to mitigate the effects of these disparities across diverse groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.